Sorry, you need to enable JavaScript to visit this website.
EIF

The discussion steered by S Aparna, Secretary, Department of Pharmaceuticals (DoP) provided an excellent opportunity for the industry captains to deliberate on PLI 2.0 address their queries on the operational details. Navdeep Rinwa, Joint Secretary and Sumit Garg, Deputy Secretary also showed a presentation on PLI 2.0 to hand-hold the participants on the operational guidelines and eligibility criteria. Dr. S Eswara Reddy, Joint Drugs Controller General of India (DCGI), Central Drugs Standard Control Organisation (CDSCO) also graced the meeting to address certain technical questions related to the scheme. The outreach event witnessed a participation of 120+ attendees.

DOP

 

We are India's national investment facilitation agency.

image

For further queries on this subject, please get in touch with us @Invest India.
Raise your query